About US
Contact us
-
Novo's Victoza won't face Teva copies until 2023. Can semaglutide fill the gap by then?Novo Nordisk has at least four more years to build up its newer diabetes drugs before they'll have to compete with Teva's knockoff versions of its own blockbuster Victoza. Under a new patentsettlemen2019/3/20
-
NASA calls for new vaccinations to combat virus reactivation during spaceflightResearchers from NASA’s Johnson Space Center have discovered that dormant herpes viruses reactivate during spaceflight, leading to an urgent need to develop counter-measures, including vaccination, t2019/3/19
-
Blackstone to acquire anti-rheumatism drugs maker Ayumi PharmaceuticalBlackstone’s private equity funds have signed a definitive agreement to acquire Japan-based anti-rheumatism drugs manufacturer Ayumi Pharmaceutical from Unison Capital and M3. Ayumi was established i2019/3/19
-
EC approves Merck’s Keytruda for metastatic squamous NSCLCThe European Commission (EC) has approved Merck’s anti-PD-1 therapy Keytruda as a first-line treatment for adults with metastatic squamous non-small cell lung cancer (NSCLC). The indication covers th2019/3/18
-
AstraZeneca secures ODD from FDA for saracatinib to treat IPFAstraZeneca has secured orphan drug designation (ODD) from the US Food and Drug Administration (FDA) for its potential new medicine, saracatinib, to treat a type of lung disease known as idiopathic p2019/3/18
-
Deerfield commits $100m for translational research deal with HarvardHealthcare investment firm Deerfield Management has formed a strategic partnership with Harvard University for research and development (R&D) focused on new translational medicine. Deerfield has2019/3/15
-
Common antifungal drug offers hope for cystic fibrosis treatmentNew research from the University of Illinois and the University of Iowa has showed that a common antifungal drug, called amphotericin, could help cystic fibrosis (CF) patients fight chronic lung infe2019/3/15
-
US Senate invites pharmacy benefit managers to testify on drug pricingThe US Senate Finance Committee has invited executives from five major pharmacy benefit managers (PBMs) to testify about the rising prescription medicine costs in the country. Senate chairman Chuck G2019/3/14
-
Irish scientists secure EU funding for Parkinson’s research projectThe Royal College of Surgeons in Ireland (RCSI) has been awarded a grant for a new research project that seeks to improve scientific understanding of Parkinson’s disease and lead to the development o2019/3/14
-
Pfizer’s biosimilar to Roche’s Herceptin receives approval from FDAPfizer has secured approval from the US Food and Drug Administration (FDA) for its drug Trazimera (trastuzumab-qyyp), a biosimilar medicine to Roche’s Herceptin (trastuzumab). The approval covers ind2019/3/13